HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia

BACKGROUND: Hypocellular acute myeloid leukemia (Hypo-AML) is a rare disease entity. Studies investigating the biological characteristics of hypo-AML have been largely lacking. We examined the clinical and biological characteristics, as well as treatment outcomes of hypo-AML in our institutes over a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaoxia, Fu, Weijun, Wang, Libing, Gao, Lei, Lü, Shuqin, Xi, Hao, Qiu, Huiying, Chen, Li, Chen, Jie, Ni, Xiong, Xu, Xiaoqian, Zhang, Weiping, Yang, Jianmin, Wang, Jianmin, Song, Xianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823132/
https://www.ncbi.nlm.nih.gov/pubmed/26497216
http://dx.doi.org/10.18632/oncotarget.6211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823132/
https://www.ncbi.nlm.nih.gov/pubmed/26497216
http://dx.doi.org/10.18632/oncotarget.6211

Ejemplares similares